Variations in End‐of‐Life Care and Place of Death Among People With Neurodegenerative Diagnoses: A Nationwide Registry‐Based Study
Variationen in der End-of-Life-Versorgung und dem Sterbeort bei Menschen mit neurodegenerativen Diagnosen: landesweite registerbasierte Studie
Acta Neurologica Scandinavica · 2026-01 · 2026 (1)
DOI: 10.1155/ane/7600145 ↗Auf einen Blick
In einer schwedischen Registerstudie blieb der Sterbeort bei Menschen mit neurodegenerativen Diagnosen zwischen 2013 und 2019 stabil. Die meisten starben in Pflegeheimen; spezialisierte Palliativversorgung wurde selten genutzt.
Fragestellung
Welche Trends und Unterschiede im Sterbeort bestehen bei Erwachsenen mit neurodegenerativen Diagnosen in Schweden, und wie hängen sie mit individuellen, klinischen, geografischen und sozioökonomischen Faktoren zusammen?
Methode
Populationsbasierte Registerstudie in Schweden zu Todesfällen 2013 bis 2019; deskriptive Statistik und lineare Regressionsmodelle. Motor neuron disease, Parkinson-Krankheit und Multiple Sklerose wurden getrennt analysiert.
Ergebnisse
9007 Todesfälle. Sterbeort: Pflegeheime 50,5 %, Krankenhäuser 33,6 %, private Haushalte 15,2 %. Nur 9,4 % erhielten den ICD-10-Code Z51.5; 90,5 % nutzten keine spezialisierte Palliativversorgung am Lebensende.
Schlussfolgerung der Autor:innen
Der Sterbeort blieb zeitlich stabil, bei begrenzter Nutzung spezialisierter Palliativversorgung. Krankenhausverlegungen im letzten Lebensmonat waren stark mit einem Krankenhaussterbeort assoziiert; es zeigten sich regionale und diagnosebezogene Unterschiede.
Kernaussagen
- Pflegeheime waren der häufigste Sterbeort (50,5 %).
- Nur 9,4 % hatten den ICD-10-Code Z51.5 für Palliativversorgung.
- Regionale und diagnosebezogene Unterschiede waren deutlich.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurologica Scandinavica, online erschienen am 09.11.2026. Verfasst von Anneli Ozanne und 5 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neurodegenerative diseases involve progressive deterioration and high symptom burden, requiring both neurological and palliative care. This study is aimed at identifying trends and variations in place of death for adult people with neurodegenerative diagnoses in Sweden using registry data, and at examining potential associations between place of death and individual characteristics, clinical, geographical and socioeconomic factors. Motor neuron disease, Parkinson′s disease and multiple sclerosis, representing the three largest diagnostic groups within the applied classification, were analysed separately.
Methods
A population registry study examined the place of death in people with neurodegenerative diagnoses between 2013 and 2019. Descriptive statistics and linear regression models were applied.
Results
A total of 9007 deaths were identified. Most occurred in nursing homes (50.5%), followed by hospitals (33.6%) and private homes (15.2%). No consistent temporal trends in place of death were observed. People with motor neuron disease and multiple sclerosis most commonly died in hospital, whereas those with Parkinson′s disease mainly died in nursing homes. Only 9.4% were assigned the ICD‐10 code Z51.5 for palliative care, and 90.5% did not utilise specialised palliative care at death. Region Stockholm, the capital region of Sweden, had the highest proportion of hospital deaths (38.5%). Among individuals living at home, a higher likelihood of hospital death was associated with residing in Stockholm, experiencing one or more hospital transfers, or having unplanned emergency department visits, whereas lower likelihood was associated with recorded utilisation of specialised palliative care.
Conclusions
Place of death remained stable over time, with limited use of specialised palliative care. Hospital transfers in the last month of life were strongly associated with hospital death, alongside substantial regional and diagnosis‐specific variation. These findings highlight regional and diagnosis‐specific variations in end‐of‐life care, which may indicate potential inequities, and suggest that earlier integration of neuropalliative care and greater consistency in the organisation of palliative care across regions warrant further consideration and evaluation.
Zitieren
APA
Ozanne, A., Larsdotter, C., Nyblom, S., Hedman, R., Fürst, C. J., & Öhlén, J. (2026). Variations in End‐of‐Life Care and Place of Death Among People With Neurodegenerative Diagnoses: A Nationwide Registry‐Based Study. Acta Neurologica Scandinavica, 2026(1). https://doi.org/10.1155/ane/7600145
Vancouver
Ozanne A, Larsdotter C, Nyblom S, Hedman R, Fürst CJ, Öhlén J. Variations in End‐of‐Life Care and Place of Death Among People With Neurodegenerative Diagnoses: A Nationwide Registry‐Based Study. Acta Neurologica Scandinavica. 2026;2026(1). doi:10.1155/ane/7600145
BibTeX
@article{Ozanne2026,
author = {Ozanne, Anneli and Larsdotter, Cecilia and Nyblom, Stina and Hedman, Ragnhild and Fürst, Carl Johan and Öhlén, Joakim},
title = {Variations in End‐of‐Life Care and Place of Death Among People With Neurodegenerative Diagnoses: A Nationwide Registry‐Based Study},
journal = {Acta Neurologica Scandinavica},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ane/7600145}
}
EUVIMED